Topical therapy in the management of chronic rhinosinusitis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 21, Issue 1, 2013, Pages 31-38

  Huang, Alice ^a   Govindaraj, Satish ^b  

^a ALBANY MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

chronic sinusitis; saline irrigations; topical antibiotics; topical antifungal; topical corticosteroid; topical therapy

Indexed keywords

AMPHOTERICIN B; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CEFUROXIME; CIPROFLOXACIN; CORTICOSTEROID; FOSFOMYCIN SODIUM; GENTAMICIN; HYDROCORTISONE; LEVOFLOXACIN; MOMETASONE FUROATE; PSEUDOMONIC ACID; SODIUM CHLORIDE; TERBINAFINE; TOBRAMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL GROWTH; CHRONIC RHINOSINUSITIS; CONTROLLED CLINICAL TRIAL (TOPIC); ENDOSCOPIC SINUS SURGERY; EPISTAXIS; FUNGUS GROWTH; HEADACHE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; META ANALYSIS (TOPIC); MUCOCILIARY CLEARANCE; MULTICENTER STUDY (TOPIC); NASAL LAVAGE; NAUSEA; NOSE OBSTRUCTION; NOSE POLYP; PARTICLE SIZE; PEAK NASAL INSPIRATORY FLOW; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; RHINORRHEA; SIDE EFFECT; SKIN IRRITATION; SNEEZING; SYSTEMATIC REVIEW (TOPIC); TOPICAL TREATMENT; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CHRONIC DISEASE; ENDOSCOPY; HUMANS; NEBULIZERS AND VAPORIZERS; RHINITIS; SINUSITIS; SODIUM CHLORIDE;

EID: 84872836768     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32835bc4ab     Document Type: Review

References (83)

1. Wingrave W. A clinical lecture on the nature of discharges and douches. Lancet 1902; 159:1373-1375.
2. MacLusky I, Levision H, Gold R, McLaughlin FJ. Inhaled antibiotics in cystic fibrosis: is there a therapeutic effect? J Pediatr 1986; 108:861-865.
3. Diot P, Gagnadoux F, Martin C, et al. Nebulization and anti-Pseudomonas aeruginosa activity of colistin. Eur Respir J 1997; 10:1995-1998.
4. Jensen T, Pedersen SS, Garne S, et al. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 1987; 19:831-838.
5. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Paediatr Pulmonol 1997; 23:330-335.
6. Roth C, Gebhart J, Just-Nubling G, et al. Characterization of amphotericin B aerosols for inhalation treatment of pulmonary aspergillosis. Infection 1996; 14:354-360.
7. Ewig S, Schafer H, Rockstroh JK, et al. Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia. Eur Respir J 1996; 9:1006-1012.
8. Goh YH, Goode RL. State of the art review: current status of topical nasal antimicrobial agents. The Laryngoscope 2000; 110:875-880.
9. Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps Group, EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007: a summary for otorhinolaryngologists. Rhinology 2007; 45:97-101.
10. Katzenstein AL, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983; 72: 89-93.
11. Robson JM, Hogan PG, Benn RA, Gatenby PA. Allergic fungal sinusitis presenting as a paranasal sinus tumour. Austi N Z J Med 1989; 19:351-353.
12. Rabago D, Zgierska A, Peppard P, Bamber A. The prescribing patterns of Wisconsin family physicians surrounding saline nasal irrigation for upper respiratory conditions. WMJ 2009; 108:145-150.
13. Pinto JM, Elwany S, Baroody FM, Naclerio RM. Effects of saline sprays on symptoms after endoscopic sinus surgery. Am J Rhinol 2006; 20:191-196.
14. Freeman SR, Sivayoham ES, Jepson K, de Carpentier J. A preliminary randomised controlled trial evaluating the efficacy of saline douching following endoscopic sinus surgery. Clin Otolaryngol 2008; 33:462-465.
15. Liang KL, Su MC, Tseng HC, Jiang RS. Impact of pulsatile nasal irrigation on the prognosis of functional endoscopic sinus surgery. J Otolaryngol 2008; 37:148-153.
16. Heatley DG, McConnell KE, Kile TL, Leverson GE. Nasal irrigation for alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg 2001; 125:44-48.
17. Pynnonen MA, Mukerjj SS, Kim HM, et al. Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otorlaryngol Head Neck Surg 2007; 133:1115-1120.
18. BoekWM,Keles N, Graamans K, Huizing EH. Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope 1999; 109:396-399.
19. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000; 110:1189-1193.
20. Rabago D, Zgierska A, Mundt M, et al. Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. J Family Pract 2002; 51:1049-1055.
21. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007: CD006394.
22. Culig J, Leppee M, Vceva A, Djanic D. Efficiency of hypertonic and isotonic seawater solutions in chronic rhinosinustis. Med Glas Ljek komore Zenicko-doboj kantona 2010; 7:116-123.
23. Hauptman G, Ryan MW. The effect of saline solutions on nasal patency and mucociliary clearance in rhinosinusitis patients. Otolaryngology 2007; 137:815-821.
24. Sowerby LJ, Wright ED. Tap water or ''sterile water'' for sinus irrigations: what are our patients using? Int Forum Allergy Rhinol 2012; 2:300-302.
25. Psaltis AJ, Foreman A, Wormald PJ, Schlosser RJ. Contamination of sinus irrigation devices: A review of the evidence and clinical relevance. Am J Rhinol Allergy 2012; 26:201-203.
26. Kofonow JM, Bhuskute A, Doghramji L, et al. One way valve bottle contamination rates in the immediate postfunctional endoscopic sinus surgery period. Am J Rhinol Allergy 2011; 25:393-396.
27. Welch KC, Cohen MB, Dogharmji LL, et al. Clinical correlation between irrigation bottle contamination and clinical outcomes in post functional endoscopic sinus surgery patients. AM J Rhinol Allergy 2008; 4:401-404.
28. Lee JM, Nayak JV, Doghramji LL, et al. Assessing the risk of irrigation bottle and fluid contamination after endoscopic sinus surgery. Am J Rhinol Allergy 2010; 24:197-199.
29. Kamijyo A, Matsuzaki Z, Kikushima K, et al. Fosfomycin nebulizer therapy to chronic sinusitis. Auris Nasus Larynx 2001; 28:227-232.
30. Uren B, Psaltis A, Wormald P-J. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope 2008; 118: 1677-1680.
31. Scheinberg PA, Otsuki A. Nebulized antibiotic for the treatment of acute exacerbations of chronic rhinosinusitis. Ear Nose Throat J 2002; 81:648-652.
32. Lim M, Citardi MJ, Leong JL. Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol 2008; 22:381-389.
33. Woodhouse BM, Cleveland KW. Nebulized antibiotics for the treatment of refractory bacterial chronic rhinosinusitis. Ann Pharmacother 2011; 45:798-802.
34. Saijo R, Majima Y, Hyo N, Takano H. Particle depositon of therapeutic aerosols in the nose and paranasal sinuses after transnasal sinus surgery: case model study. Am J Rhinol 2004; 18:1-7.
35. Hilton C, Wiedmann T, St Martin M, et al. Differential depositon of aerosols in the maxillary sinus of human cadaevers by particle size. Am J Rhinol 2008; 22:395-398.
36. Hyo N, Takano H, Hyo Y. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus. Rhinology 1989; 27:17-26.
37. Whatley WS, Chandra RK, Macdonald CB. Systemic absorption of gentamicin nasal irrigations. Am J Rhinol 2006; 20:251-254.
38. Wong KK, Marglani O, Westerberg BD, Javer AR. Systemic absorption of topical gentamicin sinus irrigation. J Otolaryngol Head Neck Surg 2008; 37:395-398.
39. Giger R, Pasche P, Cheseaux C, et al. Comparison of once-versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and nonallergic chronic rhinosinusitis. Eur Arch Oto Rhino Laryngol 2003; 260:135-140.
40. Jorissen M, Bachert C. Effect of corticosteroids on wound healing after endoscopic sinus surgery. Rhinology 2009; 47:280-286.
41. Snidvongs K, Kalish L, Sacks R, et al. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev 2011: CD009274.
42. Jankowski R, Schrewelius C, Bonfils P, et al. Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch Otolaryngol Head Neck Surg 2001; 127:447-452.
43. Tos M, Svendstrup F, Arndal H, et al. Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps. Am J Rhinol 1998; 12:183-189.
44. Filiaci F, Passali D, Puxeddu R, Schrewelius C. A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis. Rhinology 2000; 38:185-190.
45. Snidvongs K, Pratt E, Chin D, et al. Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis. Int Forum Allerg Rhinol 2012; 2:415-421.
46. Rotenberg BW, Zhang I, Arra I, Payton KB. Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial. Laryngoscope 2011; 121:2702-2705.
47. Stjarne P, Blomgren K, Caye-Thomasen P, et al. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta Otolaryngol 2006; 126:606-612.
48. Stjarne P, Mosges R, Jorissen M, et al. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg 2006; 132:179-185.
49. Stjarne P, Olsson P, Alenius M. Use of mometasone furoate to prevent polyp relapse after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 2009; 135:296-302.
50. Small CB, Hernandez J, Reyes A, et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol 2005; 116:1275-1281.
51. Lipworth BJ, Seckl JR. Measures for detecting systemic bioactivity with inhaled and intra-nasal corticosteroids. Thorax 1997; 52:476-482.
52. Esmailpour N, Hogger P, Rohdewald P. Binding of glucocorticoids to human nasal tissue in vitro. Int Arch Allergy Immunol 2000; 122:151-154.
53. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148:S1-S26.
54. Thorsson L, Borga O, Edsbacker S. Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder. Br J Clin Pharmacol 1999; 47:619-624.
55. Bhalla RK, Payton K, Wright ED. Safety of budesonide in saline sinonasal irrigations in the management of chronic rhinosinusitis with polyposis: lack of significant adrenal suppression. J Otolaryngol 2008; 37:821-825.
56. Welch KC, Thaler ER, Doghramji LL, et al. The effects of serum and urinary cortisol levels of topical intranasal irrigations with budesonide added to saline in patients with recurrent polyposis after endoscopic sinus surgery. Am J Rhinol Allergy 2010; 24:26-28.
57. Salid RJ, Howarth PH. Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Safety. 2003; 26:863-893.
58. Brannan MD, Herron JM, Reidenberg P, Affrime MB. Lack of HPA suppression following 36 days of intranasal mometasone furoate. Ann Allergy Asthma Immunol 1997; 78:154.
59. Cave A, Arlett P, Lee E. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther 1999; 83:153-179.
60. Jennings BH, Andersson KE, Johansson SA. Assessment of systemic effects of inhaled glucocorticoids, the influence of the frequency of blood sampling technique on plasma cortisol and leucocytes. Eur J Clin Pharmacol, 1990; 39:127-131.
61. Mantovani K, Bisanha AA, Demarco RC, et al. Mazillary sinuses microbiology from patients with chronic rhinosinusitis. Braz J Otorhinolaryngol 2010; 76:548-551.
62. Nigro JF, Nigro CE, Marone SA, Voegels RL. Microbiology of the maxillary and ethmoid sinuses in patients with chronic rhinosinusitis submitted to functional endoscopic sinus surgery. Braz J Otorhinolaryngol 2006; 72:217-222.
63. Mitchell TG. Overview of basic medical mycology. Otolaryngol Clin North Am 2000; 33:237-249.
64. Evigor H, Evigor M, Gunel C, et al. Characterization of fungi in chronic rhinosinusitis using polymerase chain reaction and sequencing. Eur Arch Otorhinolaryngol 2008; 265:651-656.
65. Shin SH, Ye MK, Lee YH. Fungus culture of the nasal secretion of chronic rhinosinusitis patients: seasonal variations in Daegu Korea. Am J Rhinol 2007; 5:556-559.
66. Araujo E, Dall C, Cantarelli V, et al. Microbiology of middle meatus in chronic rhinosinusitis. Braz J Otorhinolaryngol 2007; 73:549-555.
67. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusistis. Mayo Clin Proc 1999; 74:877-884.
68. Kern EB, Sherris D, Stergiou AM, et al. Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B. Ther Clin Risk Manag 2007; 3:319-325.
69. Corraginj C, Del Ninno M, Buonomo A, et al. Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection. J Investig Allergol Clin Immunol 2006; 16:188-193.
70. Ponikau JU, Sherris DA, Kita H, Kern EB. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002; 110:862-866.
71. Gerlinger I, Fittler A, Fonai F, et al. Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. Eur Arch Otorhinolaryngol 2009; 266:847-855.
72. Ricchetti A, Landis BN, Maffioli A, et al. Effect of antifungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002; 116:261-263.
73. Ebbens FA, Georgalas C, Luiten S, et al. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope 2009; 119:401-408.
74. Helbing A, Baumann A, Hanni C, Caversaccio M. Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol 2006; 120:1023-1025; Epub 2006 Sept 11
75. Weschta M, Rimek D, Formanek M, et al. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004; 113:1122-1128.
76. Ebbens FA, Scadding GK, Badia L, et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006; 118:1149-1156.
77. Stankiewicz JA, Musgrave BK, Scianna JM. Nasal amphotericin irrigation in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 44-46.
78. Sacks PL, Harvey RJ, Rimmer J, et al. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev 2011:CD008263.
79. Isaacs S, Fakhri S, Luong A, Citardi MJ. A meta-analysis of topical amphotericin B for the treatment of chronic rhinosinusitis. Int Forum Allergy Rhinol 2011; 1:250-254.
80. Weschta M, Rimek D, Formanek M, et al. Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2006; 132:743-747.
81. Liang KL, Su MC, Shiao JY, et al. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study. Am J Rhinol 2008; 22:52-58.
82. Kennedy DW, Kuhn FA, Hamilo DL, et al. Treatment of chronic rhinosinusitis with high dose oral terbinafine: a double blind placebo controlled study. Laryngoscope. 2005; 115:1793-1799.
83. Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airbourne fungi. J Allergy Clin Immunol 2004; 114:1369-1375.